Is there a clinically meaningful difference between carprofen and meloxicam for chronic pain management in dogs?

Question

Accepted Answer

Carprofen and meloxicam are clinically equivalent for chronic pain management in dogs with osteoarthritis — no evidence supports superiority of either drug. Both produce significant improvement in ground reaction forces, lameness, weight-bearing, pain on palpation, and owner-assessed mobility, but direct head-to-head data are limited to two trials, and the overall strength of evidence is rated weak.1 The most informative direct comparison found that meloxicam-treated dogs had ground reaction forces return to normal baseline values, with owners reporting gait improvement, while carprofen-treated dogs also showed significant improvement in the same parameters.1 However, the ground reaction force data were not conclusive across all parameters, no validated owner metrology instrument was used, and one of the two comparative trials provided no statistical analysis — only a descriptive suggestion that meloxicam performed better.1 Neither finding is sufficient to recommend one drug over the other. Meloxicam is dosed at 0.2 mg/kg PO on day 1, then 0.1 mg/kg PO q24h from day 2 onward, a regimen validated across two placebo-controlled field studies totaling 277 dogs, with statistically significant improvement in all veterinarian- and owner-assessed parameters at 14 days.10 Carprofen's efficacy for osteoarthritis is well-established as an active comparator — 89.1% of carprofen-treated dogs demonstrated overall improvement at approximately six weeks in a 134-day trial, and the benefit continued to increase through day 44 and was sustained through day 134.9 Long-term NSAID use in dogs does not show increased organ-based toxicity with extended treatment and demonstrates a positive trend toward increased efficacy over time.5 Gastrointestinal toxicity is the most commonly recognized adverse effect class for NSAIDs as a group.8 At 5× the recommended meloxicam dose, acute renal failure developed by day 4, fecal occult blood was detected, and gastrointestinal mucosal lesions ranging f